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Abstract
Background: In malaria endemic areas, host genetics influence whether a Plasmodium falciparum-infected child
develops uncomplicated or severe malaria. TLR2 has been identified as a receptor for P. falciparum-derived
glycosylphosphatidylinositol (GPI), and polymorphisms within the TLR2 gene may affect disease pathogenesis.
There are two common polymorphisms in the 5’ un-translated region (UTR) of TLR2, a 22 base pair deletion in the
first unstranslated exon (Δ22), and a GT dinucleotide repeat in the second intron (GTn).
Methods: These polymorphisms were examined in a Ugandan case control study on children with either cerebral
malaria or uncomplicated malaria. Serum cytokine levels were analysed by ELISA, according to genotype and
disease status. In vitro TLR2 expression was measured according to genotype.
Results: Both Δ22 and GTn polymorphisms were highly frequent, but only Δ22 heterozygosity was associated with
protection from cerebral malaria (OR 0.34, 95% confidence intervals 0.16, 0.73). In vitro, heterozygosity for Δ22 was
associated with reduced pam3cys inducible TLR2 expression in human monocyte derived macrophages. In
uncomplicated malaria patients, Δ22 homozygosity was associated with elevated serum IL-6 (p = 0.04), and long GT
repeat alleles were associated with elevated TNF (p = 0.007).
Conclusion: Reduced inducible TLR2 expression may lead to attenuated pro-inflammatory responses, a potential
mechanism of protection from cerebral malaria present in individuals heterozygous for the TLR2 Δ22
polymorphism.
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Background
In some holoendemic countries, individuals are bitten by
malaria-infected mosquitoes 60-300 times a year [1,2].
The most common form of malaria in endemic coun-
tries is uncomplicated malaria, characterized by fever,
chills, sweats, headaches and nausea. Cerebral malaria is
a severe neurologic complication of Plasmodium falci-
parum infection that occurs much less commonly than
uncomplicated malaria. Genetic factors influence
infection outcome, and polymorphisms in genes encod-
ing proteins involved in disease pathogenesis are strong
candidates for disease association studies. As a receptor
for parasite derived GPI, TLR2 is likely involved in dis-
ease pathogenesis [3], however, a previous study exam-
ining single nucleotide polymorphisms (SNPs) within
TLR2 could not detect an association with severe dis-
ease because these SNPs were absent in the populations
studied [4]. Reportedly, TLR2 SNPs are absent in some
African countries as well, but insertion deletion poly-
morphisms within the 5’ un-translated region of TLR2
are very common [5,6]. A 22 bp insertion/deletion poly-
morphism (TLR2 Δ22) in the first un-translated exon
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population but was not associated with a disease pheno-
type [5,7]. A GT dinucleotide repeat that varies by
approximately 12 to 30 repeats (GTn)i sp r e s e n tw i t h i n
the second intron, approximately 100 bp upstream of
the translational start site. Repeats of varying length
have been associated with susceptibility to tuberculosis,
reversal reactions in leprosy and colorectal cancer
[8-10]. These polymorphisms are associated with altered
in vitro phenotypes. The TLR2 Δ22 polymorphism was
associated with reduced constitutive luciferase reporter
activity compared to a construct containing the inser-
tion allele [7]. Shorter GTn repeats are associated with
reduced TLR2 reporter activity and TLR2 surface
expression in vitro [8]. Altered TLR2 expression in indi-
viduals with different TLR2 polymorphisms may lead to
differential pro-inflammatory responses based on geno-
type. TLR2 expression on human monocytes ex vivo is
highly variable [11]. Reports on pam3cys and LPS indu-
cible TLR2 expression on human monocytes vary, likely
due to donor specific differences as monocytes differ-
entiate into macrophages [11,12]. Plasmodium falci-
parum derived GPI activate TLR2 to induce TNF, IL-12,
IL-6 and nitric oxide in murine bone marrow derived
macrophages [3]. Elevated levels of IFN-g,T N F ,I L - 1 2 ,
IL-6, IL-1b, and IL-10 are initially protective, although
excessive serum levels of these cytokines are associated
with cerebral malaria pathology [13-15]. Similarly, IFN-g
and TNF are necessary for disease in the murine model
of cerebral malaria [16-19]. In the children examined in
this study, cerebral malaria patients had elevated serum
levels of IFN-g, IL-1b, and IL-10 compared to uncompli-
cated malaria patients [20]. Although neither IL-6 nor
TNF serum levels were correlated with severe disease in
these children [20] these cytokines are often associated
with severe disease in other epidemiologic studies [13].
In the current study, the role of TLR2 insertion/dele-
tion polymorphisms, Δ22 and GTn, in the pathogenesis
of cerebral malaria was evaluated. Genomic DNA and
serum were collected from Ugandan children participat-
ing in a case control study examining children with cer-
ebral malaria and uncomplicated malaria. This data
indicates heterozygosity for Δ22 polymorphism was pro-
tective (odds ratio 0.34, 95% CI 0.16-0.73), but there
was no disease association with the GTn polymorphism.
In malaria naïve donors, Δ22 heterozygosity was asso-
ciated with reduced pam3cys induced TLR2 stimulation
in human monocyte derived macrophages. In Ugandan
children involved in the case control study, none of
these polymorphisms was associated with serum cyto-
kines in the cerebral malaria group. In the uncompli-
cated malaria group, homozygosity for the Δ22 insertion
allele was associated with elevated IL-6 (p = 0.04), and
at least one long GT repeat allele was associated with
elevated serum TNF levels (p = 0.007). This data sug-
gests that the TLR2 insertiond e l e t i o np o l y m o r p h i s m s
may be involved in cerebral malaria pathogenesis
through alteration of induced TLR2 expression and
down-regulation of specific pro-inflammatory cytokines.
Methods
Children aged three-12 years were recruited for a study
assessing complications of cerebral malaria, which was
conducted at Mulago Hospital in Kampala, Uganda [20].
Eighty-five children with cerebral malaria (CM) and 76
children with uncomplicated malaria (UM) were
recruited. Children with CM were included in the study
if they were admitted to Mulago Hospital, and met the
WHO criteria for CM: coma (Blantyre coma scale ≤2,
Glasgow coma scale ≤8), P. falciparum-smear positive,
and no other signs of encephalopathy. Lumbar puncture
was performed to rule out meningitis or encephalitis.
Children with UM were enrolled at the acute-care clinic
or a malaria outpatient clinic that is sponsored by the
University of California San Francisco (UCSF). Children
were enrolled as UM patients if they exhibited the signs
and symptoms of malaria (fever, chills, vomiting, head-
ache), were P. falciparum-smear positive, had no
malaria-related complications (e.g. seizures, coma, severe
anaemia, or respiratory distress), no other sign of acute
illness, and were not hospitalized for their malarial ill-
ness. Details of study enrolment have been reported pre-
viously [20]. Genetic testing was requested from study
participants upon follow-up testing at two years after
enrolment. If consent was obtained from the study par-
ticipant parent or guardian, testing for TLR polymorph-
isms was performed on the filter paper samples
collected at initial enrolment.
Exclusion criteria for children in all three groups was
(1) a history of meningitis or encephalitis, or any other
brain disorder (including CM); (2) a history of devel-
opmental delay; (3) prior admission to the hospital for
malnutrition; (4) a history of chronic illness. Ethical
approval for these studies was granted by the institu-
tional review boards for human studies at Makerere
University Faculty of Medicine, University Hospitals of
Cleveland, Case Western Reserve University, Indiana
Wesleyan University, and the University of Minnesota.
Upon admission, study participants’ blood was col-
lected onto Whatman filter paper (Whatman Corpora-
tion, Florham Park, NJ). Genomic DNA was extracted
from dried blood spots using the QIAamp 96 spin
blood kit (QIAGEN, Valencia, CA). Presence of P. fal-
ciparum was determined by light microscopy of thin
and thick blood smear with two independent readings.
A third independent reading was performed if neces-
sary to resolve any discrepancies between the initial
two readings.
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Genomic DNA was extracted from blood using the
QIAamp 96 spin blood kit (QIAGEN, Valencia, CA).
PCR was performed using a master mix consisting of 1×
PCR buffer, 125μM dNTPs, 2.5 mM MgCl2, 125nM pri-
mers, and 0.8 units Taq polymerase in a reaction
volume of 25μl. PCR primers and amplification condi-
tions have been described previously [5]. TLR2 Δ22 gen-
otypes were assigned based on size discrimination of
PCR products on a 4% agarose gel. TLR2 GTn genotypes
were assigned based on size discrimination of PCR pro-
ducts run on a 6% polyacrylamide gel as described else-
where [21].
Cloning and sequencing
PCR amplification products from local donors were pur-
ified using the QIAquick PCR purification kit (QIAGEN,
Valencia, CA). Purified PCR products were sent to
MWG Biotech, High Point, NC for sequencing.
Sequences were analysed using the Sequencher software
(Gene Codes Corporation, Ann Arbor, MI).
Cytokine testing
Serum levels of IFNg,T N F ,I L - 1 b, IL-10, and IL6 in
children with uncomplicated malaria and cerebral
malaria were compared according to TLR2 genotype.
Serum samples for cytokine measurement were obtained
at the time of admission (CM) or outpatient enrollment
(UM). Cytokine testing was done using cytometric bead
array (CBA) technology using the Bioplex-Luminex sys-
tem (Austin TX), or ELISA as previously described
[6,20].
Statistical analysis
Allele and genotype frequencies were calculated for the
different polymorphisms, and the Hardy-Weinberg exact
test (estimation of p-values by the Markov chain
method) was performed for each population using Arle-
quin version 3.01[22]. Haplotypes were statistically
inferred using the Expectation - Maximization method
in Arlequin. Chi squared test was used to determine
allelic, genotypic, and haplotypic associations using SPSS
for Windows (version 13.0). Genotypic tests were per-
formed for additive, dominant, recessive, and heterozy-
gote advantage models. Odds ratios were performed for
the different genotype models using an online calculator
[23]. All cytokines were log transformed to create a nor-
malized distribution, and comparisons for the different
genotype models were made using the T-test using SPSS
for windows (version 13.0). Because of errors due to
multiple comparisons, Bonferroni correction assuming
two individuals tests was applied. At a false positive rate
of 5%, the adjusted significance threshold becomes p <
.025.
TLR2 expression by flow cytometry
Venous blood was collected from 18 malaria naïve
North American volunteers. Peripheral blood mononuc-
lear cells were isolated by Ficoll-Paque separation (GE
Healthcare, Piscataway, NJ) and stained with TLR2-
FITC (clone TL2.1) and CD14-APC (clone 61D3, eBios-
ciences, San Diego, CA). Cells were read on an LSRII
flow cytometer (BD Biosciences, Franklin Lakes, NJ).
Monocytes were distinguished by scatter characteristics
and CD14 positivity. Median fluorescence intensity of
isotype controls were subtracted from each sample to
determine relative TLR2 fluorescence. Ethical approval
for these studies was granted by the institutional review
board for University Hospitals of Cleveland, Case Wes-
tern Reserve University.
Cell culture
Peripheral blood mononuclear cells (PBMC) were cul-
tured in RPMI 10% human serum AB, 2 mM L-glut, 20
mM HEPES, and pen/strep. PBMC were plated out at 1
×1 0
6 cells/ml and stimulated with Pam3Cys (200 ng/
ml) for 24 h. Human monocytes were isolated by immu-
nomagnetic purification using the Miltenyi monocyte
isolation kit II (miltneyi) to obtain unlabelled monocytes
which were 80-95% pure. Purified monocytes were cul-
tured for six days in RPMI supplemented with 2 mM L-
glut, 20 mM HEPES, pen/strep, and 10% autologous
serum to allow differentiation into monocyte derived
macrophages. Cells were washed three times with PBS,
and adherent cells were removed with cell dissociation
buffer (vendor) for flow cytometry.
Parasite culture
Plasmodium falciparum strain 3D7 parasites were cul-
tured and the parasite life cycle was synchronized as
described [24]. Trophozoites and schizonts were
obtained by magnetic purification. Late stage parasite
cultures were washed three times with Macs buffer
( P B S ,p H7 . 2 ,0 . 5 %F B S ,a n d2m ME D T A ) ,a n dr e s u s -
pended at a concentration of 2 × 10
9 cells/ml. Parasite
cultures were passed through Miltenyi LD columns
(Miltenyi), allowing uninfected RBCs and rings to pass
through the column. Miltenyi columns were washed two
times 1 ml Macs buffer, and late stage parasites were
eluted with 3 ml Macs buffer. Trophs/schizonts were
washed three times and counted. Schizonts were lysed
by sonication (40 V, 10 mins). Following sonication,
schizonts were brought up to the appropriate concentra-
tion in RPMI. Schizonts or intact trophozoites were
added to macrophage cultures at a ratio of 10:1.
RT-qPCR
Approximately 1 × 10
6 monocytes were isolated for
qPCR. Total RNA was extracted using the PureLink
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reverse transcribed into cDNA using commercial
reagents (Invitrogen) and non-specific Oligo-DT pri-
mers. Quantitative PCR was carried out using the fol-
lowing gene specific primers; TLR2 - forward 5’-
ATTGTGCCCATTGCTCTTTC-3’,r e v e r s e ,5 ’-
CTTCCTTGGAGAGGCTGATG-3’;G A P D H-f o r w a r d
5’-AAGATCATCAGCAATGCCTCCTGC-3’, reverse 5’-
ATGGACTGTGGTCATGAGTCCTTC-3’. Samples
were analysed on a 7300 Real Time PCR System
(Applied Biosystems), and normalized using the com-
parative threshold method [25,26]. HEK cell mRNA was
used as a negative control for TLR2 expression.
Results
TLR2 Δ22 and GTn genetic association with cerebral
malaria
A total of 65 children with cerebral malaria and 52 chil-
dren with uncomplicated malaria were genotyped for
TLR2 insertion-deletion polymorphisms. The Δ22 poly-
morphism was highly polymorphic in this study, but
there was no significant difference in allele frequency
between the two groups (0.27 in the cerebral malaria
group vs 0.35 in the uncomplicated malaria group, p =
0.20). The GTn polymorphism was highly polymorphic
but similarly distributed between the two groups, as
demonstrated in Figure 1.
TLR2 Δ22 and GTn genotype frequencies are dis-
played in Table 1. The heterozygote advantage genotype
model best fits the Δ22 polymorphism, as heterozygosity
was significantly more common in the uncomplicated
malaria group compared to the cerebral malaria group
(WD vs DD/WW, p = .005 OR 0.34, 95%CI 0.16-0.73),
and this was below the adjusted significance threshold
of p < 0.025. Additionally, in the uncomplicated malaria
group there was a slight deviation from Hardy Weinberg
Equilibrium (p = 0.065), indicating an excess of hetero-
z y g o t e si nt h i sg r o u p .C o n s i s t e n tw i t hh o wt h eG T n
repeats have been analysed previously [8,27], the alleles
were classified as short (S < 16), medium (M, 16-23),
and long (L > 23) repeats. All individuals possessed at
least one medium length repeat allele. Only SM, MM,
and ML genotypes for the GTn repeat polymorphism
were present in the groups studied here, and these gen-
otypes were similarly distributed between cerebral
malaria patients and controls with uncomplicated
m a l a r i a( T a b l e1 ) .TLR2 haplotype frequencies are pre-
sented in Table 2. All six possible TLR2 haplotypes were
present, and similarly distributed in each group. There
was no linkage disequilibrium between these two
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Figure 1 GT repeat allele frequencies in Ugandan children.
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r
2 value >0.8 (UM D’ = 0.553, r
2 = 0.083; CM D’ =
0.490, r
2 = 0.094).
Constitutive TLR2 expression on human monocytes and
monocyte derived macrophages
Malaria naïve North American volunteers were recruited
and genotyped for TLR2 Δ22 and GTn polymorphisms.
TLR2 expression was highly variable on monocytes from
local donors ex vivo, and was not associated with Δ22
genotype in this study (Figure 2). Because of the few
donors with small or large GT repeat polymorphisms in
this study, the effect of this polymorphism on TLR2
expression on human monocytes ex vivo could not be
determined. Reportedly, TLR2 expression on monocytes
varies in the first 24 h of culture, as the cells become
adherent and begin differentiating into macrophages
[11,12,28]. To test whether differentiation dependent
TLR2 expression was based on TLR2 Δ22 genotypes,
TLR2 mRNA and protein expression were determined
on monocytes at 0, 4, and 24 h in culture. Consistent
with previous reports, TLR2 expression varied during
the first 24 h in culture, but expression levels were not
associated with genotype (Figure 2).
Inducible TLR2 expression
Because of the variability in TLR2 expression during the
first 24 h of monocyte culture, constitutive and induci-
ble TLR2 expression on human monocyte derived
macrophages was examined. Human monocytes were
isolated by negative selection and cultured for six days
to allow differentiation into macrophages. Although
constitutive TLR2 expression was not associated with
Δ22 genotype (Figure 3), a 24-h Pam3Cys stimulation
significantly up-regulated TLR2 expression on macro-
phages from homozygous donors (p = 0.023), but not
on macrophages from heterozygous donors (p =0 . 2 0 ) .
P. falciparum strain 3D7 parasites were synchronously
cultured to trophozoite stage and added to human
monocytes derived macrophages and incubated for 24 h.
Neither intact, infected RBCs or uninfected RBCs up-
regulated TLR2 expression on human monocyte derived
macrophages (Figure 3). Lysed infected RBCs were also
unable to up-regulate TLR2 expression on human
monocyte derived macrophages (data not shown).
Serum cytokine levels in children with different TLR2
polymorphisms
Serum TNF, IFN-g,I L - 1 b, IL-6, and IL-10 did not vary
based on either TLR2 Δ22 or GTn genotype in children
with cerebral malaria (Figures 4 and 5 and Additional
file 1: Table S1). In the uncomplicated malaria group,
children with at least one long GTn repeat allele pro-
duced the most TNF (p = 0.007, Figure 5 and Addi-
tional file 1: Table S1), and children homozygous for
Δ22 produced the most IL-6 compared to children with
other genotypes (p = 0.041, Figure 4 and Additional file
1 :T a b l eS 1 ) .O n l yf i v eu n c o m plicated malaria patients
had detectable serum IL-1b levels, and they were all het-
erozygous for Δ22 and had medium length GT repeat
alleles (Figures 4, 5, and Additional file 1: Table S1).
Discussion
This is the first study to show an association between
severe malaria and a TLR2 polymorphism. TLR2 Δ22
heterozygosity was significantly more common in the
uncomplicated malaria group (p = 0.005), indicating that
the odds of cerebral malaria are 66% (odds ratio 0.34,
95% CI 0.16-0.73) lower in heterozygotes compared to
either homozygote. Due to the low frequency of Δ22
Table 1 TLR2 Δ22, and GTn genotypes
Polymorphism Genotype Cerebral malaria n = 65 Uncomplicated malaria n = 52 p value OR 95% CI
Δ22 W/W 36(56.3) 18(35.3) .025
I 0.42 0.20-0.98
W/D 21(32.8) 30(58.8)
II .005
III 0.34 0.16-0.73
D/D 7(10.9) 3(5.9)
GTn SM 12(19.4) 8(16.7)
MM 46(74.2) 34(70.8)
ML 4(6.4) 6(12.5)
OR and 95% CI presented only for p values where p < 0.05
I p value for dominant genotype test, WD/DD vs WW
IIp = 0.065 for Hardy Weinberg Test of equilibrium, excess of heterozygotes
III p value for heterozygote advantage genotype test, WD vs DD/WW
Table 2 TLR2 haplotypes
Haplotype Cerebral malaria Uncomplicated malaria
D S 0.078 0.083
D M 0.185 0.265
D L 0.000 0.006
W S 0.021 0.000
W M 0.684 0.589
W L 0.033 0.057
D, deletion allele, W, wild type
S < 16 repeats, M 16-23 repeats, L > 23 repeats
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genotype model (p = 0.025, OR 0.20-0.90) is also a pos-
sibility, and future studies with larger samples sizes need
to be conducted to more precisely define the role of this
polymorphism in susceptibility to cerebral malaria.
Future studies should investigate whether this poly-
morphism is protective against other forms of severe
malaria, such as severe malarial anaemia. Individual co-
infections may have influenced the frequencies of TLR2
genotypes observed here. The Δ22 polymorphism was
associated with enhanced susceptibility to acute adeno-
lymphangitis events in lymphatic filariasis-infected
Papua New Guineans (Greene et al., unpublished
results). Lymphatic filariasis is one of many parasitic dis-
eases transmitted in Uganda [29] and the relatively low
frequency of Δ22 homozygotes in the uncomplicated
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Figure 2 Constitutive TLR2 expression on primary monocytes. TLR2 expression on CD14+ cells immediately ex vivo or during the first 24 h
in culture is shown here. Figure A is TLR2 expression on CD14+ cells ex vivo according to Δ22 genotype. Relative fluorescence is median fitc-
TLR2 fluorescence minus median fitc-isotype fluorescence for each individual. Horizontal bars indicate median for each group, and each dot
represents one donor. Representative histograms and the gate used to identify monocytes is represented in D and E. Figure B shows TLR2
protein expression on immunopurified monocytes during the first 24 h in culture according to Δ22 genotype. Error bars indicate mean +/− SEM.
There are four heterozygotes and four homozygotes are in each group. Figure C shows the corresponding TLR2 mRNA expression in the first 24
h of culture according to TLR2 Δ22 genotype. Relative mRNA expression was quantified according to the comparative Ct method, using GAPDH
as the housekeeping gene, and HEK cell mRNA as a negative control. In graph C the results at 0 h for one heterozygous donor was removed,
this person was an outlier, with a 2
-ΔΔCt value of 3.3 × 10
8.
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sures in this region.
Within the TLR2 gene, Δ22 is located in the first
untranslated exon of TLR2, approximately 60 bp down-
stream of an NF-kB site critical for chromatin remodel-
ling and transcription factor binding [28]. The GTn
repeat is located approximately 100 bp upstream of the
transcriptional start site, potentially affecting inclusion
of the single coding exon in the transcript. Because of
their location within the 5’ UTR and proximity to criti-
cal cis-elements within the TLR2 gene, it is possible that
Δ22 and GTn may affect TLR2 expression. Although
short and long GT repeats were too uncommon in local
donors to detect a difference in TLR2 expression, there
was reduced TLR2 expression in response to pam3cys
in human monocyte derived macrophages. There was a
similar, although insignificant hypo-responsiveness in
human monocytes from Δ22 heterozygotes (data not
shown). The focus was on macrophages in this study to
avoid donor specific effects on monocyte differentiation
and subsequent TLR2 expression. There was no signifi-
cant TLR2 up-regulation in response to either intact
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Figure 3 Inducible TLR2 expression on macrophages according to TLR2 Δ22 genotype. Human monocyte derived macrophages were
stimulated with pam3cys (200 ng/ml), schizont infected RBCs (3 × 10
6/well), or uninfected RBCs (3 × 10
6/well) for 24 h. TLR2 protein expression
is expressed as relative fluorescence. Top panel n = 5 homozygotes, n = 5 heterozygotes, bottom panel, n = 4 homozygotes, n = 5
heterozygotes. Error bars represent standard error of the mean.
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out the possibility that P. falciparum may directly up-
regulate TLR2, but it was not detected in this study,
possibly because there was insufficient GPI activating
TLR2 in either of the parasite preparations to up-regu-
late TLR2 expression in a manner similar to pam3cys
induction. Future studies should examine whether puri-
fied parasite derived GPI up-regulate TLR2. None of the
North American donors homozygous for Δ22, and
therefore the effect of this genotype on either constitu-
tive or inducible TLR2 expression could not be
determined.
The reduced pam3cys inducible TLR2 expression on
macrophages from Δ22 heterozygous donors suggests
that this polymorphism may attenuate TLR2 induced
signalling cascades and downstream cytokine produc-
tion. To test this, serum cytokine responses were exam-
ined in the Ugandan children involved in the case
control study according toΔ22 and GTn genotypes.
There was no significant association between the TLR2
polymorphisms examined here and serum cytokines in
the cerebral malaria group. In the uncomplicated
malaria group Δ22 homozygosity was associated with
elevated IL-6 production (p = 0.04), and at least one
long GTn allele was associated with elevated serum TNF
(p = 0.007). In these children, neither IL-6 nor TNF
were correlated with severe disease [20], though the
relatively small sample size may have precluded
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Figure 4 Cytokine levels according to Δ22 genotype in children with cerebral malaria or uncomplicated malaria. Cytokine levels are
present as pg/ml, horizontal bars indicated median. 0.01 values are actually below the threshold of detection, and were considered 0 for
statistical purposes.
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tion regarding sample size applies to the detection of
elevated levels of cytokines in children with Δ22 homo-
zygosity and cerebral malaria. This study should be
repeated in an area where elevated IL-6 and TNF corre-
late with severe disease. It is possible that cytokine pro-
duction in individuals with specific TLR2 genotypes may
influence development of uncomplicated malaria, and
future studies of longitudinal cohorts examining the
intensity and frequency of uncomplicated malaria epi-
sodes in children with different Δ22 and GTn genotypes
may elucidate the relationship between TLR2 genotype
and infection outcome. Examining serum cytokines is
non-specific, and many cells contribute to serum
cytokine levels. Future studies should examine PBMCs
from donors with different TLR2 genotypes and mea-
sure cytokine responses upon stimulation with intact
and lysed infected RBCs. One potentially confounding
variable in the current case control study would be the
presence of a MAL SNP Ser180Leu. This molecule is a
downstream adaptor in the TLR2 signalling pathway,
and this polymorphism is associated with protection
from malaria and reduced signalling in vitro [30]. The
Ugandan samples were genotyped for the MAL poly-
morphism as described previously [5]. The SNP was
present at 1.5% allele frequency in the cerebral malaria
patients, and 1% allele frequency in the uncomplicated
malaria group. Because of the low frequency of this
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Figure 5 Cytokine levels according to TLR2 GT repeat genotype in children with cerebral malaria or uncomplicated malaria.C y t o k i n e
levels are present as pg/ml, horizontal bars indicated median. 0.01 values are actually below the threshold of detection, and were considered 0
statistically.
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Page 9 of 11SNP, it is unlikely that it had a significant effect on the
serum cytokine levels observed here.
Conclusions
Collectively, this data suggest that heterozygosity for a
22 bp deletion within the first un-translated exon of
TLR2 is associated with protection from cerebral
malaria, and that this protection may be due to a dam-
pening of the pro-inflammatory response. Pam3Cys
inducible TLR2 expression was significantly reduced in
macrophages from heterozygous donors. Reduced sur-
face expression may attenuate TLR2 mediated
responses. Although there were no significant differ-
ences in serum cytokines according to TLR2 genotypes
in children with cerebral malaria, future studies examin-
ing responses to pam3cys and parasitized RBCs in
donors with different TLR2 genotypes will help identify
cell responsible for cytokine production.
Additional material
Additional file 1: Table S1. Cytokine association tests according to TLR2
genotype in Uganda children with cerebral malaria or uncomplicated
malaria.
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